Difference between revisions of "Clear cells in the kidney"
Jump to navigation
Jump to search
(One intermediate revision by the same user not shown) | |||
Line 9: | Line 9: | ||
*[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | *[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | ||
*[[ELOC-mutated renal cell carcinoma]]. | *[[ELOC-mutated renal cell carcinoma]]. | ||
*[[Xp11.2 translocation carcinoma]]. | *[[Xp11.2 translocation carcinoma]]. | ||
*[[Epithelioid angiomyolipoma]].{{fact}} | *[[Epithelioid angiomyolipoma]].{{fact}} | ||
Line 18: | Line 17: | ||
*[[Melanotic Xp11 translocation renal cancer]]. | *[[Melanotic Xp11 translocation renal cancer]]. | ||
*[[Tuberous sclerosis-associated renal cell carcinoma]]. | *[[Tuberous sclerosis-associated renal cell carcinoma]]. | ||
*[[Renal cell carcinoma with fibromyomatous stroma]].<ref>{{cite journal |authors=Shah RB, Mehra R |title=Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up |journal=Adv Anat Pathol |volume= |issue= |pages= |date=October 2023 |pmid=37899532 |doi=10.1097/PAP.0000000000000419 |url=}}</ref><ref name=pmid36592877>{{cite journal |authors=Tjota MY, Sharma A, Wanjari P, Fitzpatrick C, Segal J, Antic T |title=TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases |journal=Hum Pathol |volume=134 |issue= |pages=124–133 |date=April 2023 |pmid=36592877 |doi=10.1016/j.humpath.2022.12.015 |url=}}</ref> | |||
Benign things: | Benign things: |
Latest revision as of 03:27, 20 March 2024
Clear cells in the kidney are commonly seen in tumours and occasionally are seen in benign lesions.
RCC with clear cells redirects to here.
Recognized kidney tumours with clear cells or pale cytoplasm:
- Clear cell renal cell carcinoma.
- Clear cell papillary renal cell tumour (previously clear cell papillary renal cell carcinoma).
- ELOC-mutated renal cell carcinoma.
- Xp11.2 translocation carcinoma.
- Epithelioid angiomyolipoma.[citation needed]
- Multilocular cystic renal neoplasm of low malignant potential.
- Chromophobe renal cell carcinoma - not really "clear" cells.
Evolving entities:
- Melanotic Xp11 translocation renal cancer.
- Tuberous sclerosis-associated renal cell carcinoma.
- Renal cell carcinoma with fibromyomatous stroma.[1][2]
Benign things:
- Benign cortical cyst of the kidney.
- Benign clear cell clusters of the kidney.
- Adrenal gland cortex - biopsy of wrong anatomical site.
See also
References
- ↑ Shah RB, Mehra R (October 2023). "Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up". Adv Anat Pathol. doi:10.1097/PAP.0000000000000419. PMID 37899532.
- ↑ Tjota MY, Sharma A, Wanjari P, Fitzpatrick C, Segal J, Antic T (April 2023). "TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases". Hum Pathol 134: 124–133. doi:10.1016/j.humpath.2022.12.015. PMID 36592877.